People · Operator
Named in public records as an officer, director or promoter · active 2008–2024 · Telecommunications, Biotechnology, Other, Other Technology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Telanetix,Inc | — | Telecommunications | Series A | $12.0M | $184.0M | 2008 |
| StemBioSys Inc. | — | Biotechnology | Series A | $9.9M | $43.8M | 2020 |
| Imx, Llc | — | Other | Series A | $8.9M | $42.4M | 2022 |
| Fabri Inc. | — | Other Technology | Series A | $5.2M | $24.4M | 2024 |
| Philter Labs Inc | — | Software / Tech | Seed | $2.1M | $56.6M | 2018 |
| Theragene Pharmaceuticals, Inc. | — | Biotechnology | Pre-Seed | $548K | $11.0M | 2014 |
Steven Davis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven Davis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Robert S Langer | 1 | 14 |
| Paul Castella | 1 | 6 |
| Jean Cheever | 1 | 2 |
| Mark Horsey | 1 | 2 |
| David Rane | 1 | 2 |
| Alex Poulin | 1 | 2 |
| Peter Savas | 1 | 2 |
| Thomas Cole | 1 | 2 |
| John Feik | 1 | 2 |
| Catherine W Burzik | 1 | 1 |
| Ian W Clements | 1 | 1 |
| Chen W Xiao-Dong | 1 | 1 |
| Jean W Cheever | 1 | 1 |
| Steven W Davis | 1 | 1 |
| Paul W Castella | 1 | 1 |
| Steven Davis, M.D. | 1 | 1 |
| Mark D Horsey | 1 | 1 |
| Robert D Hutchens | 1 | 1 |
| John W Feik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.